222 related articles for article (PubMed ID: 22777352)
1. Arg/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivo.
Gil-Henn H; Patsialou A; Wang Y; Warren MS; Condeelis JS; Koleske AJ
Oncogene; 2013 May; 32(21):2622-30. PubMed ID: 22777352
[TBL] [Abstract][Full Text] [Related]
2. An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion.
Mader CC; Oser M; Magalhaes MA; Bravo-Cordero JJ; Condeelis J; Koleske AJ; Gil-Henn H
Cancer Res; 2011 Mar; 71(5):1730-41. PubMed ID: 21257711
[TBL] [Abstract][Full Text] [Related]
3. Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cells.
Srinivasan D; Plattner R
Cancer Res; 2006 Jun; 66(11):5648-55. PubMed ID: 16740702
[TBL] [Abstract][Full Text] [Related]
4. A Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivo.
Jallal H; Valentino ML; Chen G; Boschelli F; Ali S; Rabbani SA
Cancer Res; 2007 Feb; 67(4):1580-8. PubMed ID: 17308097
[TBL] [Abstract][Full Text] [Related]
5. Abl kinases are required for invadopodia formation and chemokine-induced invasion.
Smith-Pearson PS; Greuber EK; Yogalingam G; Pendergast AM
J Biol Chem; 2010 Dec; 285(51):40201-11. PubMed ID: 20937825
[TBL] [Abstract][Full Text] [Related]
6. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional signature induced by a metastasis-promoting c-Src mutant in a human breast cell line.
Broecker F; Hardt C; Herwig R; Timmermann B; Kerick M; Wunderlich A; Schweiger MR; Borsig L; Heikenwalder M; Lehrach H; Moelling K
FEBS J; 2016 May; 283(9):1669-88. PubMed ID: 26919036
[TBL] [Abstract][Full Text] [Related]
8. Src Promotes Metastasis of Human Non-Small Cell Lung Cancer Cells through Fn14-Mediated NF-κB Signaling.
Wang W; Liu F; Wang C; Wang C; Tang Y; Jiang Z
Med Sci Monit; 2018 Mar; 24():1282-1294. PubMed ID: 29500337
[TBL] [Abstract][Full Text] [Related]
9. Aggressive breast cancer cells are dependent on activated Abl kinases for proliferation, anchorage-independent growth and survival.
Srinivasan D; Sims JT; Plattner R
Oncogene; 2008 Feb; 27(8):1095-105. PubMed ID: 17700528
[TBL] [Abstract][Full Text] [Related]
10. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
[TBL] [Abstract][Full Text] [Related]
11. p140Cap dual regulation of E-cadherin/EGFR cross-talk and Ras signalling in tumour cell scatter and proliferation.
Damiano L; Di Stefano P; Camacho Leal MP; Barba M; Mainiero F; Cabodi S; Tordella L; Sapino A; Castellano I; Canel M; Frame M; Turco E; Defilippi P
Oncogene; 2010 Jun; 29(25):3677-90. PubMed ID: 20453886
[TBL] [Abstract][Full Text] [Related]
12. Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling.
Britschgi A; Bill A; Brinkhaus H; Rothwell C; Clay I; Duss S; Rebhan M; Raman P; Guy CT; Wetzel K; George E; Popa MO; Lilley S; Choudhury H; Gosling M; Wang L; Fitzgerald S; Borawski J; Baffoe J; Labow M; Gaither LA; Bentires-Alj M
Proc Natl Acad Sci U S A; 2013 Mar; 110(11):E1026-34. PubMed ID: 23431153
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
Tan M; Yao J; Yu D
Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
[TBL] [Abstract][Full Text] [Related]
14. PTP1B promotes cell proliferation and metastasis through activating src and ERK1/2 in non-small cell lung cancer.
Liu H; Wu Y; Zhu S; Liang W; Wang Z; Wang Y; Lv T; Yao Y; Yuan D; Song Y
Cancer Lett; 2015 Apr; 359(2):218-25. PubMed ID: 25617799
[TBL] [Abstract][Full Text] [Related]
15. Lyn kinase mediates cell motility and tumor growth in EGFRvIII-expressing head and neck cancer.
Wheeler SE; Morariu EM; Bednash JS; Otte CG; Seethala RR; Chiosea SI; Grandis JR
Clin Cancer Res; 2012 May; 18(10):2850-60. PubMed ID: 22490227
[TBL] [Abstract][Full Text] [Related]
16. miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer.
Mutlu M; Saatci Ö; Ansari SA; Yurdusev E; Shehwana H; Konu Ö; Raza U; Şahin Ö
Sci Rep; 2016 Sep; 6():32541. PubMed ID: 27600857
[TBL] [Abstract][Full Text] [Related]
17. Loss of AF6/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth.
Fournier G; Cabaud O; Josselin E; Chaix A; Adélaïde J; Isnardon D; Restouin A; Castellano R; Dubreuil P; Chaffanet M; Birnbaum D; Lopez M
Oncogene; 2011 Sep; 30(36):3862-74. PubMed ID: 21478912
[TBL] [Abstract][Full Text] [Related]
18. SRC tyrosine kinase inhibitor, m475271, suppresses subcutaneous growth and production of lung metastasis via inhibition of proliferation, invasion, and vascularization of human lung adenocarcinoma cells.
Zheng R; Yano S; Matsumori Y; Nakataki E; Muguruma H; Yoshizumi M; Sone S
Clin Exp Metastasis; 2005; 22(3):195-204. PubMed ID: 16158247
[TBL] [Abstract][Full Text] [Related]
19. Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells.
Fan Y; Si W; Ji W; Wang Z; Gao Z; Tian R; Song W; Zhang H; Niu R; Zhang F
Breast Cancer Res; 2019 May; 21(1):66. PubMed ID: 31113450
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation.
Li H; Huang F; Fan L; Jiang Y; Wang X; Li J; Wang Q; Pan H; Sun J; Cao X; Wang X
Oncogene; 2014 Sep; 33(37):4589-98. PubMed ID: 24276246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
